학술논문
Associations of diabetes status and glucose measures with outcomes after endovascular therapy in patients with acute ischemic stroke: an analysis of the nationwide TREAT-AIS registry
Document Type
article
Author
Meng-Tsang Hsieh; Cheng-Yang Hsieh; Tzu-Hsien Yang; Sheng-Feng Sung; Yi-Chen Hsieh; Chung-Wei Lee; Chun-Jen Lin; Yu-Wei Chen; Kuan-Hung Lin; Pi-Shan Sung; Chih-Wei Tang; Hai-Jui Chu; Kun-Chang Tsai; Chao-Liang Chou; Ching-Huang Lin; Cheng-Yu Wei; Te-Yuan Chen; Shang-Yih Yan; Po-Lin Chen; Chen-Yu Hsiao; Lung Chan; Yen-Chu Huang; Hon-Man Liu; Sung-Chun Tang; I-Hui Lee; Li-Ming Lien; Hung-Yi Chiou; Jiunn-Tay Lee; Jiann-Shing Jeng
Source
Frontiers in Neurology, Vol 15 (2024)
Subject
Language
English
ISSN
1664-2295
Abstract
BackgroundHyperglycemia affects the outcomes of endovascular therapy (EVT) for acute ischemic stroke (AIS). This study compares the predictive ability of diabetes status and glucose measures on EVT outcomes using nationwide registry data.MethodsThe study included 1,097 AIS patients who underwent EVT from the Taiwan Registry of Endovascular Thrombectomy for Acute Ischemic Stroke. The variables analyzed included diabetes status, admission glucose, glycated hemoglobin (HbA1c), admission glucose-to-HbA1c ratio (GAR), and outcomes such as 90-day poor functional outcome (modified Rankin Scale score ≥ 2) and symptomatic intracranial hemorrhage (SICH). Multivariable analyses investigated the independent effects of diabetes status and glucose measures on outcomes. A receiver operating characteristic (ROC) analysis was performed to compare their predictive abilities.ResultsThe multivariable analysis showed that individuals with known diabetes had a higher likelihood of poor functional outcomes (odds ratios [ORs] 2.10 to 2.58) and SICH (ORs 3.28 to 4.30) compared to those without diabetes. Higher quartiles of admission glucose and GAR were associated with poor functional outcomes and SICH. Higher quartiles of HbA1c were significantly associated with poor functional outcomes. However, patients in the second HbA1c quartile (5.6–5.8%) showed a non-significant tendency toward good functional outcomes compared to those in the lowest quartile (